RGC (Regencell Bioscience Holdings) EV-to-Revenue : (As of Jun. 27, 2025)

Regencell Bioscience Holdings EV-to-Revenue Chart

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-Revenue	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Regencell Bioscience Holdings's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's EV-to-Revenue falls into.

Regencell Bioscience Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Regencell Bioscience Holdings's EV-to-Revenue for today is calculated as:

Regencell Bioscience Holdings's current Enterprise Value is $10,737.37 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regencell Bioscience Holdings's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings  (NAS:RGC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Regencell Bioscience Holdings's PS Ratiofor today is calculated as:

Regencell Bioscience Holdings's share price for today is $20.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings Business Description